“The state-of-the-art technology will be part of Singapore’s national screening programme and is expected to deliver a tremendous recurring income for the group over the long term, ” Nova MSC Bhd said in a statement yesterday.
KUALA LUMPUR: EyRIS Pte Ltd has won a five-year contract from the Singapore Health Ministry for the deployment of its first artificial intelligence-based product, Selena+.
EyRIS is 42% owned by novaHEALTH Pte Ltd which is wholly-owned by Nova MSC Bhd
.
